The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-thrombin III Testing Market Research Report 2025
Synopsis
Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.
The global Anti-thrombin III Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Anti-thrombin III Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-thrombin III Testing.
Report Scope
The Anti-thrombin III Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-thrombin III Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-thrombin III Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Segment by Type
Diagnosis of antithrombin deficiency
Activity assays
Immunological assays
Segment by Application
Hospital
Research institute
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-thrombin III Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.
The global Anti-thrombin III Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Anti-thrombin III Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-thrombin III Testing.
Report Scope
The Anti-thrombin III Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-thrombin III Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-thrombin III Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.
Segment by Type
Diagnosis of antithrombin deficiency
Activity assays
Immunological assays
Segment by Application
Hospital
Research institute
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-thrombin III Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-thrombin III Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnosis of antithrombin deficiency
1.2.3 Activity assays
1.2.4 Immunological assays
1.3 Market by Application
1.3.1 Global Anti-thrombin III Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research institute
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-thrombin III Testing Market Perspective (2019-2030)
2.2 Anti-thrombin III Testing Growth Trends by Region
2.2.1 Global Anti-thrombin III Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-thrombin III Testing Historic Market Size by Region (2019-2024)
2.2.3 Anti-thrombin III Testing Forecasted Market Size by Region (2025-2030)
2.3 Anti-thrombin III Testing Market Dynamics
2.3.1 Anti-thrombin III Testing Industry Trends
2.3.2 Anti-thrombin III Testing Market Drivers
2.3.3 Anti-thrombin III Testing Market Challenges
2.3.4 Anti-thrombin III Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-thrombin III Testing Players by Revenue
3.1.1 Global Top Anti-thrombin III Testing Players by Revenue (2019-2024)
3.1.2 Global Anti-thrombin III Testing Revenue Market Share by Players (2019-2024)
3.2 Global Anti-thrombin III Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-thrombin III Testing Revenue
3.4 Global Anti-thrombin III Testing Market Concentration Ratio
3.4.1 Global Anti-thrombin III Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-thrombin III Testing Revenue in 2023
3.5 Anti-thrombin III Testing Key Players Head office and Area Served
3.6 Key Players Anti-thrombin III Testing Product Solution and Service
3.7 Date of Enter into Anti-thrombin III Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-thrombin III Testing Breakdown Data by Type
4.1 Global Anti-thrombin III Testing Historic Market Size by Type (2019-2024)
4.2 Global Anti-thrombin III Testing Forecasted Market Size by Type (2025-2030)
5 Anti-thrombin III Testing Breakdown Data by Application
5.1 Global Anti-thrombin III Testing Historic Market Size by Application (2019-2024)
5.2 Global Anti-thrombin III Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-thrombin III Testing Market Size (2019-2030)
6.2 North America Anti-thrombin III Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Anti-thrombin III Testing Market Size by Country (2019-2024)
6.4 North America Anti-thrombin III Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-thrombin III Testing Market Size (2019-2030)
7.2 Europe Anti-thrombin III Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Anti-thrombin III Testing Market Size by Country (2019-2024)
7.4 Europe Anti-thrombin III Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-thrombin III Testing Market Size (2019-2030)
8.2 Asia-Pacific Anti-thrombin III Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-thrombin III Testing Market Size (2019-2030)
9.2 Latin America Anti-thrombin III Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Anti-thrombin III Testing Market Size by Country (2019-2024)
9.4 Latin America Anti-thrombin III Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-thrombin III Testing Market Size (2019-2030)
10.2 Middle East & Africa Anti-thrombin III Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anti-thrombin III Testing Introduction
11.1.4 Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Danaher Corp.
11.2.1 Danaher Corp. Company Detail
11.2.2 Danaher Corp. Business Overview
11.2.3 Danaher Corp. Anti-thrombin III Testing Introduction
11.2.4 Danaher Corp. Revenue in Anti-thrombin III Testing Business (2019-2024)
11.2.5 Danaher Corp. Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Detail
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2019-2024)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Siemens Healthcare GmbH
11.4.1 Siemens Healthcare GmbH Company Detail
11.4.2 Siemens Healthcare GmbH Business Overview
11.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Introduction
11.4.4 Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2019-2024)
11.4.5 Siemens Healthcare GmbH Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Detail
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2019-2024)
11.5.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
